Literature DB >> 25824782

Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.

Ian Campbell1, Nina Scott, Sanjeewa Seneviratne, James Kollias, David Walters, Corey Taylor, David Roder.   

Abstract

BACKGROUND: The Quality Audit (BQA) program of the Breast Surgeons of Australia and New Zealand (NZ) collects data on early female breast cancer and its treatment. BQA data covered approximately half all early breast cancers diagnosed in NZ during roll-out of the BQA program in 1998-2010. Coverage increased progressively to about 80% by 2008. This is the biggest NZ breast cancer database outside the NZ Cancer Registry and it includes cancer and clinical management data not collected by the Registry. We used these BQA data to compare socio-demographic and cancer characteristics and survivals by ethnicity.
MATERIALS AND METHODS: BQA data for 1998-2010 diagnoses were linked to NZ death records using the National Health Index (NHI) for linking. Live cases were followed up to December 31st 2010. Socio-demographic and invasive cancer characteristics and disease-specific survivals were compared by ethnicity.
RESULTS: Five-year survivals were 87% for Maori, 84% for Pacific, 91% for other NZ cases and 90% overall. This compared with the 86% survival reported for all female breast cases covered by the NZ Cancer Registry which also included more advanced stages. Patterns of survival by clinical risk factors accorded with patterns expected from the scientific literature. Compared with Other cases, Maori and Pacific women were younger, came from more deprived areas, and had larger cancers with more ductal and fewer lobular histology types. Their cancers were also less likely to have a triple negative phenotype. More of the Pacific women had vascular invasion. Maori women were more likely to reside in areas more remote from regional cancer centres, whereas Pacific women generally lived closer to these centres than Other NZ cases.
CONCLUSIONS: NZ BQA data indicate previously unreported differences in breast cancer biology by ethnicity. Maori and Pacific women had reduced breast cancer survival compared with Other NZ women, after adjusting for socio-demographic and cancer characteristics. The potential contributions to survival differences of variations in service access, timeliness and quality of care, need to be examined, along with effects of co- morbidity and biological factors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824782     DOI: 10.7314/apjcp.2015.16.6.2465

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Risk factors for breast cancer in the breast cancer risk model study of Guam and Saipan.

Authors:  Rachael T Leon Guerrero; Rachel Novotny; Lynne R Wilkens; Marie Chong; Kami K White; Yurii B Shvetsov; Arielle Buyum; Grazyna Badowski; Michelle Blas-Laguaña
Journal:  Cancer Epidemiol       Date:  2017-10       Impact factor: 2.984

2.  Treatment and survival of Asian women diagnosed with breast cancer in New Zealand.

Authors:  Chunhuan Lao; Ross Lawrenson; Melissa Edwards; Ian Campbell
Journal:  Breast Cancer Res Treat       Date:  2019-06-05       Impact factor: 4.872

3.  Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?

Authors:  Sandar Tin Tin; J Mark Elwood; Charis Brown; Diana Sarfati; Ian Campbell; Nina Scott; Reena Ramsaroop; Sanjeewa Seneviratne; Vernon Harvey; Ross Lawrenson
Journal:  BMC Cancer       Date:  2018-01-08       Impact factor: 4.430

4.  The Expression Level of BRCA2 and Its Changes during Chemotherapy in Patients with Different Pathological Types of Mammary Cancer.

Authors:  Yu Huang; Min Luo; Junqing Huang; Shaoxin Huang; Liuxia Wei; Yumei Zhang; Zhiming Zhang
Journal:  Iran J Public Health       Date:  2019-09       Impact factor: 1.429

5.  Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.

Authors:  J Mark Elwood; Essa Tawfiq; Sandar TinTin; Roger J Marshall; Tung M Phung; Ian Campbell; Vernon Harvey; Ross Lawrenson
Journal:  BMC Cancer       Date:  2018-09-17       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.